Impax Lab announced (in a press release Here ) that it has initiated a challenge of the patents listed by Genzyme Corporation in connection with its Renvela® (sevelamer carbonate) 800 mg tablets.
Earlier, innovator sued generic companies like Impax (as reported by us Here) and Lupin (as reported by us Here) for filing ANDA for Sevelamer Hydrochloride.
Earlier, innovator sued generic companies like Impax (as reported by us Here) and Lupin (as reported by us Here) for filing ANDA for Sevelamer Hydrochloride.
No comments:
Post a Comment